KEGG   DRUG: Bapineuzumab
Entry
D08867                      Drug                                   
Name
Bapineuzumab (USAN/INN)
Formula
C6466H10018N1734O2026S44
Exact mass
145782.1896
Mol weight
145871.9913
Class
Neuropsychiatric agent
 DG01968  Antidementia agent
Efficacy
Dementia therapeutic agent
Comment
Monoclonal antibody
Treatment of Alzheimer's disease
Target
Amyloid beta [CPD:C16514 C16515]
Structure map
map07056  Agents for Alzheimer-type dementia
Brite
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01968  Antidementia agent
   D08867  Bapineuzumab
Other DBs
CAS: 648895-38-9
PubChem: 96025550

» Japanese version   » Back

DBGET integrated database retrieval system